

Orgenesis shares are trading lower by 23% during Monday's session. The company announced a 1-for-10 reverse stock split.
You can purchase shares of ORGENESIS INC by Orgenesis, Inc. (OTCEM:ORGS) through any online brokerage.
There are no as such competitors for ORGENESIS INC by Orgenesis, Inc..
There is no analysis for ORGENESIS INC by Orgenesis, Inc. to provide a consensus price target.
The stock price for ORGENESIS INC by Orgenesis, Inc. (OTCEM: ORGS) is $0.3 last updated November 11, 2026 at 1:58 PM EST.
There are no upcoming dividends for ORGENESIS INC by Orgenesis, Inc..
ORGENESIS INC by Orgenesis, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for ORGENESIS INC by Orgenesis, Inc..
ORGENESIS INC by Orgenesis, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system...